产品封面图
文献支持

HCC95人肺鳞癌细胞

收藏
  • ¥3500
  • 中乔新舟已认证
  • 中国
  • ZQ0978
  • 2026年03月01日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      HCC95

    • 库存

      100

    • 供应商

      中乔新舟

    • 品系

      细胞系

    • 运输方式

      常温

    • 年限

      液氮长期

    • 生长状态

      贴壁生长

    • 规格

      T25

    产品名称

    HCC95人肺鳞癌细胞

    货号

    ZQ0978

    产品介绍

    HCC95细胞系源自一位65岁男性的肺鳞状细胞癌组织,细胞表现出上皮细胞样的形态,并且是贴壁生长。主要应用于药物筛选和敏感性测试、癌症生物学研究、癌症基因组学和蛋白质组学研究、癌症转移研究、免疫治疗研究、耐药性研究、癌症治疗靶点的验证等研究。

    种属

    性别/年龄

    男性/65岁

    组织

    疾病

    鳞状细胞癌

    生物安全等级

    BSL-1

    STR位点信息

    D3S1358: 17
    vWA: 14,17
    FGA: 22
    Amelogenin: X
    TH01: 8,9
    TPOX: 8,11
    CSF1P0: 12
    D5S818: 10,11
    D13S317: 11
    D7S820: 10

    细胞类型

    肿瘤细胞

    形态学

    上皮

    生长方式

     贴壁

    倍增时间

    40.6 hours (PubMed=29681454)

    培养基和添加剂

    RPMI-1640(中乔新舟 货号:ZQ-200)+10%FBS(品牌:中乔新舟

     货号:ZQ0500)+1%PS(中乔新舟  货号:CSP006)

    推荐完全培养基货号

    ZM0978

    培养条件

    95%空气,5%二氧化碳;37℃

    抗原表达/受体表达

     ***

    基因表达

     ***

    保藏机构

    KCLB; 70095

    供应限制

    仅供科研使用

    上海中乔新舟生物科技有限公司成立于2011年,历经十多年发展,主要专注于细胞生物学产品的研究和开发,专注于为药企、各类科研机构及CRO企业提供符合标准规范的细胞培养服务、细胞培养基、细胞检测试剂盒、细胞培养试剂,胎牛血清和细胞生物学技术服务等。

    公司一直致力于为高等院校、研究机构、医院、CRO及CDMO企业提供细胞培养完整解决方案,这些产品旨在满足细胞培养的多样需求,确保实验和研究的有效进行。引用中乔新舟(ZQXZBIO)产品和服务的文献超数千篇。

    产品细节图片1

    产品服务

    细胞资源:原代细胞、细胞株、干细胞、示踪细胞、耐药株细胞、永生化细胞等基因工程细胞。

    试剂产品:胎牛血清、完全培养基(适用于原代细胞及细胞株)、无血清培养基、基础培养基、细胞转染试剂、重组因子、胰酶和双抗等等细胞培养所有实验相关产品。

    技术服务:稳转株构建、原代细胞分离、特殊培养基定制服务、细胞检测等。

    产品细节图片2

    目前产品已经畅销国内30多个省市,与客户建立长期的合作伙伴关系,共同实现成功。全体员工将不懈努力,继续为科研人员提供优良的产品和服务,致力成为全球细胞培养领域的参与者。

    产品细节图片3

    企业愿景

    致力于成为国内细胞培养基产业的佼佼者,生物医药领域上游原材料的优良提供商。

    企业使命

    成长为专业细胞系及原代细胞培养供应商、专业细胞培养基及培养试剂生产商。

    企业荣誉

    产品细节图片4

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

     

    PubMed=9559342; DOI=10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2
    Virmani A.K., Fong K.M., Kodagoda D.R., McIntire D., Hung J., Tonk V., Minna J.D., Gazdar A.F.
    Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types.
    Genes Chromosomes Cancer 21:308-319(1998)

     

    PubMed=10353731
    Wistuba I.I., Bryant D., Behrens C., Milchgrub S., Virmani A.K., Ashfaq R., Minna J.D., Gazdar A.F.
    Comparison of features of human lung cancer cell lines and their corresponding tumors.
    Clin. Cancer Res. 5:991-1000(1999)

     

    PubMed=10987304
    Girard L., Zochbauer-Muller S., Virmani A.K., Gazdar A.F., Minna J.D.
    Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Cancer Res. 60:4894-4906(2000)

     

    PubMed=16187286; DOI=10.1002/ijc.21491
    Garnis C., Lockwood W.W., Vucic E., Ge Y., Girard L., Minna J.D., Gazdar A.F., Lam S., MacAulay C., Lam W.L.
    High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH.
    Int. J. Cancer 118:1556-1564(2006)

     

    PubMed=19472407; DOI=10.1002/humu.21028
    Blanco R., Iwakawa R., Tang M.-Y., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.
    A gene-alteration profile of human lung cancer cell lines.
    Hum. Mutat. 30:1199-1206(2009)

     

    PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x
    Iwakawa R., Kohno T., Enari M., Kiyono T., Yokota J.
    Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma.
    Cancer Sci. 101:1891-1896(2010)

     

    PubMed=20679594; DOI=10.1093/jnci/djq279
    Gazdar A.F., Girard L., Lockwood W.W., Lam W.L., Minna J.D.
    Lung cancer cell lines as tools for biomedical discovery and research.
    J. Natl. Cancer Inst. 102:1310-1321(2010)

     

    PubMed=22460905; DOI=10.1038/nature11003
    Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
    The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
    Nature 483:603-607(2012)

     

    PubMed=22961666; DOI=10.1158/2159-8290.CD-12-0112
    Byers L.A., Wang J., Nilsson M.B., Fujimoto J., Saintigny P., Yordy J., Giri U., Peyton M., Fan Y.-H., Diao L.-X., Masrorpour F., Shen L., Liu W.-B., Duchemann B., Tumula P., Bhardwaj V., Welsh J., Weber S., Glisson B.S., Kalhor N., Wistuba I.I., Girard L., Lippman S.M., Mills G.B., Coombes K.R., Weinstein J.N., Minna J.D., Heymach J.V.
    Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
    Cancer Discov. 2:798-811(2012)

     

    PubMed=24002593; DOI=10.1038/bjc.2013.452
    Wu D., Pang Y., Wilkerson M.D., Wang D., Hammerman P.S., Liu J.S.
    Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity.
    Br. J. Cancer 109:1599-1608(2013)

     

    PubMed=25877200; DOI=10.1038/nature14397
    Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.
    A resource for cell line authentication, annotation and quality control.
    Nature 520:307-311(2015)

     

    PubMed=26589293; DOI=10.1186/s13073-015-0240-5
    Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P., Loewer M., Sahin U., Castle J.C.
    TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
    Genome Med. 7:118.1-118.7(2015)

     

    PubMed=26361996; DOI=10.1016/j.jprot.2015.09.003
    Grundner-Culemann K., Dybowski J.N., Klammer M., Tebbe A., Schaab C., Daub H.
    Comparative proteome analysis across non-small cell lung cancer cell lines.
    J. Proteomics 130:1-10(2016)

     

    PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
    Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
    Characterization of human cancer cell lines by reverse-phase protein arrays.
    Cancer Cell 31:225-239(2017)

     

    PubMed=29610121; DOI=10.1158/2159-8290.CD-17-1004
    Drilon A., Somwar R., Mangatt B.P., Edgren H., Desmeules P., Ruusulehto A., Smith R.S., Delasos L., Vojnic M., Plodkowski A.J., Sabari J., Ng K., Montecalvo J., Chang J., Tai H.-C., Lockwood W.W., Martinez V., Riely G.J., Rudin C.M., Kris M.G., Arcila M.E., Matheny C., Benayed R., Rekhtman N., Ladanyi M., Ganji G.
    Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers.
    Cancer Discov. 8:686-695(2018)

     

    PubMed=29681454; DOI=10.1016/j.cell.2018.03.028
    McMillan E.A., Ryu M.-J., Diep C.H., Mendiratta S., Clemenceau J.R., Vaden R.M., Kim J.-H., Motoyaji T., Covington K.R., Peyton M., Huffman K., Wu X.-F., Girard L., Sung Y., Chen P.-H., Mallipeddi P.L., Lee J.Y., Hanson J., Voruganti S., Yu Y., Park S., Sudderth J., DeSevo C., Muzny D.M., Doddapaneni H., Gazdar A.F., Gibbs R.A., Hwang T.H., Heymach J.V., Wistuba I.I., Coombes K.R., Williams N.S., Wheeler D.A., MacMillan J.B., DeBerardinis R.J., Roth M.G., Posner B.A., Minna J.D., Kim H.S., White M.A.
    Chemistry-first approach for nomination of personalized treatment in lung cancer.
    Cell 173:864-878.e29(2018)

     

    PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
    Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
    An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
    Cancer Res. 79:1263-1273(2019)

     

    PubMed=31068700; DOI=10.1038/s41586-019-1186-3
    Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
    Next-generation characterization of the Cancer Cell Line Encyclopedia.
    Nature 569:503-508(2019)

     

    PubMed=31395879; DOI=10.1038/s41467-019-11415-2
    Yu K., Chen B., Aran D., Charalel J., Yau C., Wolf D.M., van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.
    Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.
    Nat. Commun. 10:3574.1-3574.11(2019)

     

    PubMed=31803961; DOI=10.1002/jcb.29564
    Mulshine J.L., Ujhazy P., Antman M., Burgess C.M., Kuzmin I.A., Bunn P.A. Jr., Johnson B.E., Roth J.A., Pass H.I., Ross S.M., Aldige C.R., Wistuba I.I., Minna J.D.
    From clinical specimens to human cancer preclinical models -- a journey the NCI-cell line database-25 years later.
    J. Cell. Biochem. 121:3986-3999(2020)

     

    PubMed=31978347; DOI=10.1016/j.cell.2019.12.023
    Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E.T., Schweppe D.K., Jedrychowski M.P., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P.
    Quantitative proteomics of the Cancer Cell Line Encyclopedia.
    Cell 180:387-402.e16(2020)

    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3800
    深圳市康初源有限公司
    2026年01月22日询价
    ¥3450
    亿泽丰生物科技(上海)有限公司
    2026年04月25日询价
    ¥900
    上海淳麦生物科技有限公司
    2025年07月11日询价
    ¥780
    诺安基因科技(武汉)有限公司
    2025年07月09日询价
    ¥880
    武汉华尔纳生物科技有限公司
    2025年07月11日询价
    文献支持
    HCC95人肺鳞癌细胞
    ¥3500